Related Experiment Videos
Does interferon therapy for chronic hepatitis B reduce the risks of developing cirrhosis and hepatocellular
1Tulane University, New Orleans, LA, USA.
Hepatology (Baltimore, Md.)
|October 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Duodenal Permeability Is Associated With Mucosal Microbiota in Compensated Cirrhosis.
Clinical and translational gastroenterology·2022
[Proper patient education improves hepatitis C patients' disease-related knowledge and antiviral treatment acceptance in rural China].
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2019
Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy.
Alimentary pharmacology & therapeutics·2018
All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database.
Alimentary pharmacology & therapeutics·2016
Clinical utility of a 30% reduction in VCTE-derived liver stiffness measurement for identifying histologic improvement in MASH.
Hepatology (Baltimore, Md.)·2026
Drug-Induced Liver Injury (DILI) in clinical trials: Views and practical updates from DILI specialists at FDA.
Hepatology (Baltimore, Md.)·2026